Alps Group Inc (ALPS)
NASDAQ: ALPS · Real-Time Price · USD
0.881
-0.009 (-1.01%)
At close: Mar 6, 2026, 4:00 PM EST
0.900
+0.019 (2.16%)
After-hours: Mar 6, 2026, 6:45 PM EST
Company Description
Alps Group Inc, a biotechnology company, provides research and development, medical services, and wellness solutions for advanced therapies. The company is based in Kuala Lumpur, Malaysia.
Alps Group Inc
| Country | Malaysia |
| Founded | 2017 |
| Industry | Oil & Gas |
| Sector | Energy |
| Employees | 93 |
| CEO | Seng Tham |
Contact Details
Address: Icon Tower (East), Unit E-18-01 & E-18-02, Level 18 Kuala Lumpur, 50400 Malaysia | |
| Phone | 60 3 2163 1113 |
| Website | alps-holdings.com |
Stock Details
| Ticker Symbol | ALPS |
| Exchange | NASDAQ |
| Fiscal Year | April - March |
| Reporting Currency | USD |
| CIK Code | 0002025774 |
| CUSIP Number | G0231P108 |
| ISIN Number | KYG0231P1081 |
| SIC Code | 8000 |
Key Executives
| Name | Position |
|---|---|
| Craig William Perry | Chairman and Chief Executive Officer |
| Darren Moulds | Chief Financial Officer |
| Michael William McCoy | Chief Operating Officer |
| William Wicker | Chief Investment Officer |
| Reagan Brown | Chief Administrative Officer |
| Chrystie Holmstrom | Chief Legal Officer and Corporate Secretary |
| Chris Nilan | Senior Managing Director |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Feb 23, 2026 | 6-K | Report of foreign issuer |
| Feb 5, 2026 | 6-K | Report of foreign issuer |
| Jan 30, 2026 | 6-K | Report of foreign issuer |
| Jan 21, 2026 | 424B3 | Prospectus |
| Jan 20, 2026 | EFFECT | Notice of Effectiveness |
| Jan 8, 2026 | 6-K | Report of foreign issuer |
| Jan 7, 2026 | F-1 | Registration statement for certain foreign private issuers |
| Nov 12, 2025 | SCHEDULE 13D | Filing |
| Nov 3, 2025 | SCHEDULE 13G | Filing |
| Nov 3, 2025 | SCHEDULE 13G | Filing |